M A Larsen1, V T Isaksen2, E J Paulssen2,3, R Goll2,3, J R Florholmen2,3. 1. Research Group of Gastroenterology and Nutrition, Department of Clinical Medicine, UiT The Arctic University of Norway, Tromsø, Norway. doctorarlen@gmail.com. 2. Research Group of Gastroenterology and Nutrition, Department of Clinical Medicine, UiT The Arctic University of Norway, Tromsø, Norway. 3. Department of Nephrology and Gastroenterology, Division of Internal Medicine, University Hospital of North Norway, Tromsø, Norway.
Abstract
PURPOSE: Adipokines produced by white adipose tissue are central in the development of lifestyle diseases. Individuals in industrialized countries spend a substantial part of life in the non-fasting, postprandial state, which is associated with increased oxidation and inflammation. The aim was to study postprandial adiponectin and leptin levels after an oral fat tolerance test (OFTT) and an oral glucose tolerance test (OGTT) in obese (OB) and healthy, normal weight individuals (NW). METHODS: Fifty adults with obesity (BMI ≥ 30) and 17 healthy, NW were included. Postprandial triglyceride (TG), adiponectin, and leptin levels were measured every second hour during an 8 h OFTT, and every half hour during a 2 h OGTT. RESULTS: Compared with the basal level, postprandial levels of adiponectin following OFTT showed a slight initial peak, followed by a significant decrease at 8 h, in the NW. In the OB these changes were abolished. Postprandial levels of leptin decreased significantly from basal levels in the OFTT, in the NW, whereas in the OB, leptin was unchanged except for a slight increase from 2 to 8 h. During the OGTT both adiponectin and leptin levels remained unchanged in the NW, but decreased significantly in the OB. In addition, the OB had delayed TG clearance at 6 h. CONCLUSIONS: A fatty meal gives postprandial changes in the secretion of adiponectin and leptin in NW, but not in OB. Our observations indicate that a potential postprandial regulatory role of adiponectin and leptin is impaired in OB, and of importance in a more comprehensive understanding of the delayed postprandial TG clearance in obese individuals.
PURPOSE: Adipokines produced by white adipose tissue are central in the development of lifestyle diseases. Individuals in industrialized countries spend a substantial part of life in the non-fasting, postprandial state, which is associated with increased oxidation and inflammation. The aim was to study postprandial adiponectin and leptin levels after an oral fat tolerance test (OFTT) and an oral glucose tolerance test (OGTT) in obese (OB) and healthy, normal weight individuals (NW). METHODS: Fifty adults with obesity (BMI ≥ 30) and 17 healthy, NW were included. Postprandial triglyceride (TG), adiponectin, and leptin levels were measured every second hour during an 8 h OFTT, and every half hour during a 2 h OGTT. RESULTS: Compared with the basal level, postprandial levels of adiponectin following OFTT showed a slight initial peak, followed by a significant decrease at 8 h, in the NW. In the OB these changes were abolished. Postprandial levels of leptin decreased significantly from basal levels in the OFTT, in the NW, whereas in the OB, leptin was unchanged except for a slight increase from 2 to 8 h. During the OGTT both adiponectin and leptin levels remained unchanged in the NW, but decreased significantly in the OB. In addition, the OB had delayed TG clearance at 6 h. CONCLUSIONS: A fatty meal gives postprandial changes in the secretion of adiponectin and leptin in NW, but not in OB. Our observations indicate that a potential postprandial regulatory role of adiponectin and leptin is impaired in OB, and of importance in a more comprehensive understanding of the delayed postprandial TG clearance in obese individuals.
Authors: Sung Hee Choi; Eu Jeong Ku; Eun Shil Hong; Soo Lim; Ki Woong Kim; Jae Hoon Moon; Kyoung Min Kim; Young Joo Park; Kyong Soo Park; Hak Chul Jang Journal: Int J Cardiol Date: 2015-01-27 Impact factor: 4.164
Authors: N Mekki; M A Christofilis; M Charbonnier; C Atlan-Gepner; C Defoort; C Juhel; P Borel; H Portugal; A M Pauli; B Vialettes; D Lairon Journal: J Clin Endocrinol Metab Date: 1999-01 Impact factor: 5.958
Authors: William L Holland; Andrew C Adams; Joseph T Brozinick; Hai H Bui; Yukiko Miyauchi; Christine M Kusminski; Steven M Bauer; Mark Wade; Esha Singhal; Christine C Cheng; Katherine Volk; Ming-Shang Kuo; Ruth Gordillo; Alexei Kharitonenkov; Philipp E Scherer Journal: Cell Metab Date: 2013-05-07 Impact factor: 27.287
Authors: Marta Bueno; Susanna Esteba-Castillo; Ramon Novell; Olga Giménez-Palop; Ramon Coronas; Elisabeth Gabau; Raquel Corripio; Neus Baena; Marina Viñas-Jornet; Míriam Guitart; David Torrents-Rodas; Joan Deus; Jesús Pujol; Mercedes Rigla; Assumpta Caixàs Journal: PLoS One Date: 2016-09-29 Impact factor: 3.240